Fonte: Pharmaceutics. Unidade: FCFRP
Assuntos: FLAVONÓIDES, NANOTECNOLOGIA, DEPRESSÃO, PASSIFLORACEAE, NEUROFARMACOLOGIA, ANTIDEPRESSIVOS
ABNT
ALVES, Jovelina Samara Ferreira et al. In vivo antidepressant effect of Passiflora edulis f. flavicarpa into cationic nanoparticles: improving bioactivity and safety. Pharmaceutics, v. 12, n. 4, p. 1-19, 2020Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics12040383. Acesso em: 23 ago. 2024.APA
Alves, J. S. F., Silva, A. M. dos S., Silva, R. M. da, Tiago, P. R. F., Carvalho, T. G. de, Araújo Júnior, R. F. de, et al. (2020). In vivo antidepressant effect of Passiflora edulis f. flavicarpa into cationic nanoparticles: improving bioactivity and safety. Pharmaceutics, 12( 4), 1-19. doi:10.3390/pharmaceutics12040383NLM
Alves JSF, Silva AM dos S, Silva RM da, Tiago PRF, Carvalho TG de, Araújo Júnior RF de, Azevedo EP de, Lopes NP, Ferreira LDS, Gavioli EC, Silva-Júnior AA da, Zucolotto SM. In vivo antidepressant effect of Passiflora edulis f. flavicarpa into cationic nanoparticles: improving bioactivity and safety [Internet]. Pharmaceutics. 2020 ; 12( 4): 1-19.[citado 2024 ago. 23 ] Available from: https://doi.org/10.3390/pharmaceutics12040383Vancouver
Alves JSF, Silva AM dos S, Silva RM da, Tiago PRF, Carvalho TG de, Araújo Júnior RF de, Azevedo EP de, Lopes NP, Ferreira LDS, Gavioli EC, Silva-Júnior AA da, Zucolotto SM. In vivo antidepressant effect of Passiflora edulis f. flavicarpa into cationic nanoparticles: improving bioactivity and safety [Internet]. Pharmaceutics. 2020 ; 12( 4): 1-19.[citado 2024 ago. 23 ] Available from: https://doi.org/10.3390/pharmaceutics12040383